Effect of aromatase inhibitors on the lipid profile of postmenopausal breast cancer patients-Reference-Cited by-同舟云学术

Effect of aromatase inhibitors on the lipid profile of postmenopausal breast cancer patients

Published:2010-04-01 Issue:2 Volume:5 Page:245-254
ISSN:1758-4299
Container-title:Clinical Lipidology
language:en
Short-container-title:Clinical Lipidology

Author:

Markopoulos Christos J¹,Tsaroucha Alexandra K²,Gogas Helen J³

Affiliation:

1. Department of Surgery, Athens University Medical School, Athens, Greece

2. Department of Surgery, Democritus University of Thrace, Alexandroupolis, Greece

3. Department of Internal Medicine, Athens University Medical School, Greece

Publisher

Informa UK Limited

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism

Link

https://www.tandfonline.com/doi/pdf/10.2217/clp.10.4

Reference92 articles.

1. Gail MH, Costantino JP, Bryant J et al.: Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. J. Natl Cancer Inst. 91, 1829–1846 (1999).

2. Markopoulos C, Chrissochou M, Antonopoulou Z et al.: Duration of tamoxifen effect on lipidemic profile of postmenopausal breast cancer patients following deprivation of treatment. Oncology 70, 301–305 (2006).

3. ▪▪ Demonstrates that the beneficial effects of tamoxifen on the lipid profile discontinues in less than 12 months following cessation of treatment.

4. Hozumi Y, Kawano M, Saito T, Miyata M: Effect of tamoxifen on serum lipid metamolism. J. Clin. Endocrinol. Metab. 83, 1633–1635 (1998).

5. Decensi A, Robertson C, Ballardini B et al.: Effect of tamoxifen on lipoprotein(a) and insulin-like growth factor-I (IGF-I) in healthy women. Eur. J. Cancer 35, 596–600 (1999).

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Magnitude Mechanical Signals Combined with Zoledronic Acid Reduce Musculoskeletal Weakness and Adiposity in Estrogen-Deprived Mice;2023-03-13

2. Cardiovascular toxicity of breast cancer treatment: an update;Cancer Chemotherapy and Pharmacology;2021-04-17

3. Breast Cancer Survivors Undergoing Endocrine Therapy Have a Worrying Risk Factor Profile for Cardiovascular Diseases;Nutrients;2021-03-29

4. Steroidal aromatase inhibitors have a more favorable effect on lipid profiles than nonsteroidal aromatase inhibitors in postmenopausal women with early breast cancer: a prospective cohort study;Therapeutic Advances in Medical Oncology;2020-01